Page last updated: 2024-10-27

fluoxetine and Rectal Neoplasms

fluoxetine has been researched along with Rectal Neoplasms in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Rectal Neoplasms: Tumors or cancer of the RECTUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tutton, PJ1
Barkla, DH1

Other Studies

1 other study available for fluoxetine and Rectal Neoplasms

ArticleYear
Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas.
    British journal of cancer, 1982, Volume: 46, Issue:2

    Topics: Animals; Cell Division; Cell Line; Citalopram; Colonic Neoplasms; Epithelium; Fluoxetine; Intestines

1982